Jane Street’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Jane Street's PCVX Position: Q3 2026 in Review
Jane Street reduced its Vaxcyte (PCVX) stake by 0.05% in Q3 2026, selling an estimated $175 and leaving 6,398 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #8743.
Jane Street first reported a position in PCVX in Q2 2020 and has held it in 17 quarters since. The position peaked at $24.5M in Q4 2024. 355 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Jane Street held 6,398 shares of Vaxcyte worth $364K as of Q3 2026.
- Jane Street sold 3 Vaxcyte shares in Q3 2026, an estimated $175.
- Vaxcyte made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #8743 holding.
- Jane Street first reported a position in Vaxcyte in Q2 2020 and has held it in 17 quarters since.
- Jane Street's Vaxcyte position peaked at $24.5M in Q4 2024.
- 355 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.